Form D · Venture Capital Fund

Life Biosciences LLC

Boston, MA · CIK 0001751806

Offering snapshot reported Apr 24, 2026 · SEC filing

Reported sold
$31M
Offering amount: $31M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 25, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 24, 2026Initial$31,000,002No comparison8SEC filing
Jun 11, 2021Amendment$74,774,925$56,589,373vs Jun 12, 202035SEC filing
Sep 23, 2020Initial$0No comparison6SEC filing
Jun 12, 2020Initial$18,185,552No comparison10SEC filing
Jan 2, 2019Amendment$48,604,803$43,454,807vs Aug 31, 201845SEC filing
Aug 31, 2018Initial$5,149,996No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$30K
Form D file number
021-581853
In addition to the foregoing amount, the Issuer previously sold securities totaling $48,999,995 in the financing pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Chatsworth Securities LLC40804

Source: Form D, filed Apr 24, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bracken Darrell Director
Alexander Tristan Edwards Promoter
Stuart Gibson Director
David Guyer Director
Mehmood Khan Director, Executive
Brian Malone Executive
Gerald Mc Laughlin Director, Executive
Adam Neumann Director
Michael Ringel Executive
Sharon Rosenzweig Lipson Executive
Amit Shashank Executive
David Sinclair Director
Ilan Stern Director
Nicholas Ventresca Executive

Issuer details

Industry: Other (See others in industry)

Address:
75 Park Plaza Third Floor
Boston, MA, 02116